University of Medicine and Dentistry of New Jersey

Robert Nett, MD; Lisa K. Mannix, MD; Loretta Mueller, DO; Anthony Rodgers, MS; Carolyn M. Hustad, PhD; Franck Skobieranda, MD; Karen E. Ramsey, RPh Rizatriptan Efficacy in ICHD-II Pure Menstrual Migraine and Menstrually Related Migraine. Headache. Vol. : (2008 ) .

Mueller L Diagnosing and Managing Migraine Headache. J Am Osteop Assoc. Vol. 107: ES10-ES16 (2007 ) .

Mannix LK, Loder E, Nett R, Mueller L, Rodgers A, Hustad C, Ramsey K, Skobieranda F Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies. Cephalalgia. Vol. 27: 414-421 (2007 ) .

Gallagher RM, Alam R, Shah S, Mueller L, Rogers JJ Headache in Medical Education: Medical Schools, Neurology and Family Practice Residencies. Headache. Vol. 45: 866-873 (2005 ) .

Loder E, Silberstein SD, Abu-Shakra S, Mueller L, Smith T Efficacy and Tolerability of Oral Zolmitriptan in Menstrually Associated Migraine: A Randomized, Prospective, Parallel-Group, Double-blind, Placebo-Controlled Study. Headache. Vol. 44: 120-130 (2004 ) .

Mueller L Triptans Have Revolutionized Acute Migraine Therapy. Mueller L. Triptans Have Revolutionized Acute Migraine Therapy Osteopathic Family Physician News. Vol. 4(6): 14-16 (2004 ) .

Mueller L Cervicogenic Headache: A Diagnostic and Therapeutic Dilemma. Headache & Pain: Diagnostic Challenges, Current Therapy . Vol. 14(1): 29-37 (2003 ) .

Gallagher RM, Mueller L Managing intractable migraine with naratriptan. Headache. Vol. Oct 2003;43(9): 991-993 (2003 ) .

Gallagher RM, Mueller L L, Freitag FG Divalproex sodium in the treatment of migraine and cluster headaches. J Am Osteopath Assoc. Vol. Feb 2002;102(2): 92-94 (2002 ) .

Mueller L Tension-type, the forgotten headache: How to recognize this common but undertreated condition. Postgrad Med. Vol. 2002 Apr;111(4): 25-6, 31-2, 37-8 passim (2002 ) .

Allaryari P, McAbee GN, Mueller L, White R. Headache Characteristics in Patients After Migrainous Stroke Neurology 2002; 58(4): 668-669. Headache Characteristics in Patients After Migrainous Stroke. Neurology. Vol. 58(4): 668-669 (2002 ) .

Mueller L , Gupta AK, Stein TP Deficiency of tumor necrosis factor alpha in a subclass of menstrual migraineurs. Headache. Vol. Feb 2001;41(2): 129-137 (2001 ) .

Mueller L , Gallahger RM, Steer RA, Ciervo CA Increased prevalence of sensing types in men with cluster headaches. Psychol Rep. Vol. 2000 Oct;87(2): 555-8 (2000 ) .

Mueller L Predictability of exogenous hormone effect on subgroups of migraineurs. Headache. Vol. 2000 Mar;40(3): 189-93 (2000 ) .

Mueller L , Gupta AK, Stein TP Cytokine levels in cluster headache patients. Headache Quarterly-Current Treatment and Research. Vol. 2000;11(3): 203-210 (2000 ) .

Mueller L Psychologic aspects of chronic headache. J Am Osteopath Assoc. Vol. Sep 2000;100(9 Suppl): S14-21 (2000 ) .

Mueller L Mueller L. Managing Migraine in the Pregnant Patient The Female Patient (Ob/Gyn ed.) 2000; 25(1):16-27.. The Female Patient. Vol. 25(1): 16-27 (2000 ) .

Diamond M., Geweke L., Hendrix S., Mueller L. A New Age of Migraine Management. Patient Care. Vol. Sep 30: S1-S9 (1999 ) .

Mueller L. and Ciervo C.A. Smoking in Women. Journal of the American Osteopathic Association. Vol. 98(12 Suppl): S7-S10 (1998 ) .

Gallagher R.M., Mueller L., Steer R, and Ciervo C.A. Myers-Briggs Personality Type Classification of Migrainous Women. Gallagher R.M., Mueller L., Steer R, and Ciervo C.A., "Myers-Briggs Personality Type Classification of Migrainous Women Headache Quarterly, 1998; 9:2, 149-152.. Vol. 9(2): 149-152 (1998 ) .

Mueller L Hormonal Aspects of Migraine. Journal of the American Osteopathic Association. Vol. 98(6): S1-S5 (1998 ) .

Gallagher R.M., Mueller L., Ciervo C.A. Hydroxyzine Pamoate as an Analgesic for Headache. Headache Quarterly. Vol. : (1997 ) .

Mueller L., Gallagher R.M., and Ciervo C.A. Methylergonovine Maleate as a Cluster Headache Prophylactic: A Study and Review. Headache. Vol. 37(7): (1997 ) .

Ciervo C.A. and Mueller L. Oral Contraceptives: Considerations in Prescribing. Journal of the American Osteopathic Association. Vol. 97(8): S1-S7 (1997 ) .

Mueller L., Gallagher R.M., and Ciervo C.A. Vasospasm - Induced Myocardial Infarction with Sumatriptan. Headache. Vol. 36(5): 329-331 (1996 ) .

Ciervo C.A., Gallagher R.M., Mueller L. and Perrino D. The Role of Diet in Treated Migraine Patients. Headache Quarterly. Vol. 7(4): 319-323 (1996 ) .

Gallagher R.M., Mueller L., and Ciervo C.A. Analgesic Use in Cluster Headache. Headache. Vol. 36(2): 105-107 (1996 ) .

Top of page

Grants and Contracts

Title: The Evolution and Management of Migraine Recurrence Beyond 24 Hours: A Prospective Study of Tertiary Care Center Patients
Sponsor: Endo Pharmaceuticals
Effective Date(s): 2008 - Present
Role: Principal Investigator, Investigator Initiated

Title: A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Crossover Study to Evaluate the Efficacy of TREXIMA (Sumatriptan and Naproxen Sodium) versus Butalbital-Containing Combination Medications for the Acute Treatment of Migraine when Administered during the Moderate-Severe Pain Phase of the Migraine TRX109011
Sponsor: GlaxoSmithKline
Effective Date(s): 2008 - Present
Role: Principal Investigator

Title: A Study of Combination Product (sumatriptan succinate and naproxen sodium) in Migraine Subjects Who Report Poor Response of Intolerance to Eletriptan (Study 2 of 2) TRX106573
Sponsor: GlaxoSmithKline
Effective Date(s): 2008 - Ongoing
Role: Principal Investigator

Title: A Randomized, Double-Blind, Single Migraine Attack, Placebo-Controlled, Parallel-Group Multicenter Study to Evaluate the Efficacy and Tolerability of Trexima Tablets vs Placebo when Administered During the Mild Pain Phase of Menstrual Migraine in Women with Dysmenorrhea TRX105850
Sponsor: GlaxoSmithKline
Effective Date(s): 2006 - Ongoing
Role: Principal Investigator

Title: Childhood Maltreatment, Headache, and Comorbid Conditions
Sponsor: American Headache Society
Effective Date(s): 2006 - Ongoing
Role: Co-Investigator

Title: A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Cross-Over Study to Determine the Consistency of Trexima (Sumatriptan 85mg/Naproxen Sodium 500mg) in the Acute Treatment of Multiple Migraine Attacks TRX103635
Sponsor: GlaxoSmithKline
Effective Date(s): 2005 - Ongoing
Role: Principal Investigator

Title: A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10mg Tablet for the Treatment of Menstrual Migraine Protocol #071-00 and 072-00
Sponsor: Merck & Co., Inc
Effective Date(s): 2005 - Ongoing
Role: Principal Investigator

Title: Medical Informatics in Headache Management and its Long Term Effects on Diagnosis and Treatment of Headaches
Sponsor: National Headache Foundation
Effective Date(s): 2005 - Ongoing
Role: Co-Investigator

Title: A Double-Blind, Placebo-Controlled, Parallel Group Study with an Open-Label Extension Phase to Assess the Efficacy, Tolerability, and Safety of Oral Frovatriptan in the Prevention of Menstrually-Related Migraine Migraines in a Difficult to Treat Population Protocol #VML 251-3MRM02
Sponsor: Vernalis
Effective Date(s): 2004 - Ongoing
Role: Principal Investigator

Title: A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10mg Tablet Administered Early During a Migraine Attack While the Pain is Mild Protocol #066-00
Sponsor: Merck & Co., Inc.
Effective Date(s): 2004 - Ongoing
Role: Principal Investigator

Title: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Single-Attack Evaluation of the Efficacy and Tolerability of Trexima (sumatriptan 85mg/naproxen sodium 500mg) Tablets vs. Placebo When Administered During the Mild Phase of a Migraine Protocol #101998
Sponsor: GlaxoSmithKline
Effective Date(s): 2004 - Ongoing
Role: Principal Investigator

Title: A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10mg Tablet Administered Early During a Migraine Attack While the Pain is Mild Protocol #065-00
Sponsor: Merck & Co., Inc.
Effective Date(s): 2004 - Ongoing
Role: Principal Investigator

Title: A Phase II Safety and Efficacy Study of NPS 1776 for the Acute Treatment of Migraine Headaches
Sponsor: NPS Pharmaceuticals
Effective Date(s): 2003 - Ongoing
Role: Co-Investigator

Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Attack Study to Evaluate the Onset of Efficacy of a New Formulation of Sumatriptan Tablets 50mg and 100mg in the Acute Treatment of Migraine
Sponsor: GlaxoSmithKline
Effective Date(s): 2003 - Ongoing
Role: Principal Investigator

Title: A Comparison of the Efficacy and Safety of Ultracet (Tramadol HCL/Acetaminophen) versus Placebo for the Acute Treatment of Migraine Headache Pain
Sponsor: Ortho-McNeil
Effective Date(s): 2003 - Ongoing
Role: Principal Investigator

Title: Weight Gain Considerations in the Formulation of a Headache Treatment Regimen
Sponsor: Ortho-McNeil
Effective Date(s): 2003 - Ongoing
Role: Principal Investigator

Title: A Multi-Center, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Trial to Evaluate Early Efficacy and Tolerability of Zolmitriptan (Zomig) Nasal Spray in the Acute Treatment of Adult Subjects with Migraine
Sponsor: AstraZeneca
Effective Date(s): 2002 - 2003
Role: Principal Investigator

Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Tolerability of Oral Sumatriptan 25mg, 50mg, and 100mg for a Single Moderate or Severe Headache in Adults Diagnosed with Migrainous Disorder
Sponsor: GlaxoSmithKline
Effective Date(s): 2002 - 2003
Role: Principal Investigator

Top of page

Research Areas

migraine, chronic daily headache, cluster headache, menstrual migraine:

Top of page